1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Cardiac Disease Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Cardiac Disease Market, United States
3.1 Cardiac Disease Market, United States, Revenue ($m), 2018-2033
3.1.1 Cardiac Marker Tests Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Cardiac Disease Market, United States, Volume (Units), 2018-2033
3.2.1 Cardiac Marker Tests Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Cardiac Disease Market, United States, Average Price ($), 2018-2033
3.4 Cardiac Disease Market, United States, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in United States, Cardiac Disease Market
4.1 F. Hoffmann-La Roche Ltd
4.1.1 Company Overview
4.2 Abbott Laboratories
4.2.1 Company Overview
4.3 Danaher Corp
4.3.1 Company Overview
4.4 Quidelortho Corp
4.4.1 Company Overview
4.5 Siemens Healthineers AG
4.5.1 Company Overview
4.6 bioMerieux SA
4.6.1 Company Overview
6 Financial Deals Landscape
6.1 Acquisition
6.1.1 GenBody Acquires Kwell Laboratories (Kwell Labs)
6.2 Equity Offerings
6.2.1 Dyne Therapeutics to Raise USD300 Million in Public Offering of Shares
6.2.2 Jubilant DraxImage Radiopharmacies (Jubilant Radiopharma) to Raise USD50 Million in Private Placement
7 Recent Developments
7.1 Corporate Communications
7.1.1 Mar 03, 2025: Pulnovo secures $100m to advance clinical trials and business expansion
7.2 Government and Public Interest
7.2.1 Feb 11, 2025: New Implant May Help Patients Regenerate Their Own Heart Valves
7.3 Other Significant Developments
7.3.1 Oct 09, 2024: Heart Health for All: How We Can Improve Access to Cardiac Care around the Globe
7.3.2 Oct 08, 2024: Amwell Expands Clinical Programs Portfolio to Include Hello Heart Cardiovascular Health Risk Management Solution
7.4 Product News
7.4.1 Apr 28, 2025: Simple Blood Test Could Better Predict Heart Disease Risk
7.4.2 Feb 28, 2025: Allegheny General Hospital First in Western PA to Participate in Clinical Trial Using Artificial Intelligence to Detect Deep Vein Thrombosis in Cardiac Patients
7.4.3 Jan 28, 2025: New Data Finds 31% of Working Americans and Their Families Have a Cardiac Disorder
7.4.4 Jan 09, 2025: Peerbridge Health Unveils Cor-Insight Trial To Validate Revolutionary Ai-Enabled Cardiac and Cardiopulmonary Diagnostics & Monitoring
7.4.5 Dec 16, 2024: Streamlining Analysis of Ion Channel in Vitro Assays Data to Support Clinical Cardiac Safety Decision-Making
7.4.6 Sep 30, 2024: New Wearable Laser Device Monitors Brain Blood Flow to Gauge Stroke Risk
7.4.7 Aug 20, 2024: Brigham Researchers Use AI Tools to Uncover Connections Between Radiotherapy for Lung Cancer and Heart Complications
7.4.8 Aug 19, 2024: American Chemical Society : Improving Access to Heart-Failure Screening with Saliva
7.4.9 Jun 27, 2024: SoftWave TRT Affiliate Study Featured in Prominent Medical Journal
7.5 Strategy And Business Planning
7.5.1 Dec 18, 2024: Medera’s Novoheart Enters Into Transformative Partnership With Curi Bio
7.5.2 Jun 27, 2024: Elucid Moves into New Headquarters in Preparation for Commercial Launch
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: Cardiac Disease Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Cardiac Marker Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Cardiac Disease Market, United States, Volume (Units), 2018-2033
Table 4: Cardiac Marker Tests Market, United States, Volume (Units), 2018-2033
Table 5: Cardiac Disease Market, United States, Average Price ($), 2018-2033
Table 6: Cardiac Disease Market, United States, Company Share by Revenue ($m), 2024
Table 7: Cardiac Disease Market Pipeline Products
Table 8: GenBody Acquires Kwell Laboratories (Kwell Labs)
Table 9: Dyne Therapeutics to Raise USD300 Million in Public Offering of Shares
Table 10: Jubilant DraxImage Radiopharmacies (Jubilant Radiopharma) to Raise USD50 Million in Private Placement
Table 11: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Cardiac Disease Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Cardiac Marker Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Cardiac Disease Market, United States, Volume (Units), 2018-2033
Figure 4: Cardiac Marker Tests Market, United States, Volume (Units), 2018-2033
Figure 5: Cardiac Disease Market, United States, Company Share (%), 2024
